Subscribe to Newsletter

May 2021 Issue of The Cannabis Scientist

Introducing the Wonderful Wizards of Oz! Our May issue takes you on a tour of The University of Sydney's Lambert Initiative for Cannabinoid Therapeutics – featuring an in-depth interview with its Director, Iain McGregor. Not content with one initiative director, we also Sit Down With Ziva Cooper – Director of the UCLA Cannabis Research Initiative, University of California, Los Angeles, USA. More controversially, we share strong views on the benefits of synthetic CBD and the fact that cannabis cannot be considered a cure-all. Finally, Rich Whitworth tells us why we're gonna need a bigger fence...

Register to download
Register here to download any issue of The Cannabis Scientist for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Cannabis Scientist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Research & Development Pharmaceutical

We Need a Bigger Fence

| Rich Whitworth

When it comes to (medical) cannabis, why all the side picking?

Business & Profession Legislation & policy

A United Kingdom on Cannabis?

| Rich Whitworth

Perhaps powered by an increasingly legal US market, the medical cannabis engine across the Atlantic appears to be (slowly) building momentum
Business & Profession Legislation & policy

Protagonist or Supporting Act?

| Tomas Skrinskas

Medical cannabis is not a blockbuster drug – the plant should be considered as just one component of an overall therapy or regimen
Business & Profession Legislation & policy

Don't Cross the Streams!

| Miguel Fagundes

We need a clearer distinction between medicinal, medical, and pharmaceutical cannabis products
Testing & Processing Cannabinoid analysis

What's the Deal with Synthetic CBD?

| Richard O’Halloran

The future of cannabinoid manufacture lies not in natural plants but in chemical... plants
Research & Development Medical research

Deep Research Down Under

| Rich Whitworth

Meet the Wizards of Oz in a mini tour of The Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney
Research & Development Medical research

Found in Translation

| Rich Whitworth

Sitting Down With… Ziva Cooper, Director of the UCLA Cannabis Research Initiative

Other issues of 2021